Cannell & Spears LLC
Source: SEC Form 13F · as of Mar 2026Cannell & Spears LLC holds 26 biotech & pharma companies tracked by BioSniper, totaling $745.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$745.4M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 1,596,446 | $191.9M |
| ABTABBOTT LABORATORIES | 1,100,852 | $112.9M |
| ABBVAbbVie Inc. | 497,366 | $108.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 137,828 | $106.3M |
| JNJJOHNSON & JOHNSON | 342,814 | $83.7M |
| BMYBRISTOL MYERS SQUIBB CO | 485,184 | $29.4M |
| AXSMAxsome Therapeutics, Inc. | 168,308 | $28.4M |
| PFEPFIZER INC | 496,124 | $13.9M |
| ELVElevance Health Inc. | 47,138 | $13.6M |
| PMPhilip Morris International Inc | 59,114 | $9.8M |
| IDXXIDEXX LABORATORIES INC /DE | 14,352 | $8.1M |
| LLYELI LILLY & Co | 7,474 | $6.8M |
| AMGNAMGEN INC | 17,434 | $6.1M |
| IQVIQVIA Holdings Inc. | 35,921 | $6.0M |
| DVADaVita Inc. | 29,440 | $4.5M |
| GMOptec International, Inc. | 54,210 | $4.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 13,282 | $3.5M |
| BIIBBIOGEN INC. | 10,162 | $1.9M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 3,966 | $1.8M |
| NVSNovartis AG | 8,094 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 6,292 | $877K |
| BNTXBioNTech SE | 8,000 | $711K |
| AZNASTRAZENECA PLC | 3,332 | $652K |
| NVONovo Nordisk A/S | 14,824 | $535K |
| BAXBaxter International Inc. | 22,426 | $376K |
| ALECAlector, Inc. | 109,284 | $235K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.